Department of Health and Human Services logoNational Institutes of Health logoNational Heart, Lung, and Blood Institute
NHLBI BannerSearch
Division of Intramural Research Banner
NHLBI Logo Division of Intramural Research NHLBI Logo
LCB Banner LCB Home    NHLBI Research Home
Skip left side navigation and go to content

Sections

Cellular Biochemistry

Cellular Physiology

Membrane Biology

Molecular Cell Biology

Protein Trafficking

 

Resources

Publications

Image Gallery

Patient Recruitment

Online Research Resources

 

Contact Us

LCB Staff

 
Skip left side navigation and go to content
Skip left side navigation and go to content

Protein Trafficking

Rosa Puertollano, PhD, Principal Investigator

In the last several years an increasing number of genes associated with different human diseases have been identified. Interestingly, many of these genes have been demonstrated to encode components of the intracellular sorting machinery that mediates the selective trafficking of lipids and proteins in the secretory and endocytic pathways. Two different projects in our laboratory try to address how defects in intracellular trafficking might lead to human diseases:

hMCLN1-GFP in HeLa cells

Mutations in mucolipin-1 have been linked to mucolipidosis type IV (MLIV), a lysosomal storage disorder characterized by severe neurological and ophthalmologic abnormalities. To study the intracellular traffic of mucolipin-1 we have generated a chimera in which GFP is fused to the C-terminal end of mucolipin-1 (hMCLN1-GFP). The figure shows that over-expression of hMCLN1-GFP in HeLa cells caused a dramatic enlargement of lysosomes. These structures resemble the late endosome-lysosome hybrid organelles observed in MLIV patients.

Project 1. Mucolipidosis type IV (MLIV) is an autosomal recessive lysosome storage disorder characterized by severe psychomotor retardation and ophthalmologic abnormalities, including corneal opacity, retinal degeneration, and strabismus. Unlike the situation in other lysosomal disorders, the accumulation of heterogeneous storage material observed in MLIV does not result from the block in the catabolic pathways, but is due to a transport defect in the late steps of endocytosis. MCOLN1, the gene mutated in MLIV patients, encodes a protein called mucolipin-1 that might function as a Ca 2+ permeable channel and has been implicated in the biogenesis of lysosomes. To gain information on the mechanisms underlying this pathology we are trying to identify proteins that interact with or regulate the function of mucolipin-1 by using a combination of pull-down, yeast two hybrid screening, and siRNA techniques. In addition we are seeking to identify the sorting motifs that regulate trafficking of mucolipin-1 within the cell. So far we have found that mucolipin-1 can reach lysosomes through both a direct (from Golgi to lysosomes) and an indirect (through the plasma membrane) route. The direct route appears to be dependent on a dileucine motif located at the N-terminal cytosolic tail of the protein that mediates interaction with the clathrin adaptors AP-1 and AP-3. In contrast, the indirect pathway is dependent on an internalization motif positioned at the end of the mucolipin-1 C-terminal cytosolic tail. This sequence binds AP-2 and promotes the endocytosis of the protein from the plasma membrane through clathrin-coated vesicles. Interestingly, palmitoylation of three cysteine residues seems to regulate the efficiency of mucolipin-1 internalization.

Project 2. Growth factors and their transmembrane receptor tyrosine kinases (RTK) play important roles during embryonic development and in the regulation of several cellular processes including proliferation, survival, migration and differentiation. Binding of growth factors to their receptors activates a myriad of signaling pathways that permit cells to respond to changes in the environment. In many cases the termination of these signaling events is mediated by receptor internalization and degradation. Defects in receptor down-regulation might lead to sustained signaling and transformation. The epithelial growth factor receptor (EGFR) is considered the prototypal member of the RTK family and its activation by EGF and trafficking has been exhaustively characterized. However, there are still some aspects that remain to be addressed in more detail. One of these aspects is the role played by kinases in the regulation of EGFR trafficking. Our results show that that activation of p38 MAP kinase by anisomycin is sufficient to induce internalization of EGFR. Anisomycin and EGF employ different mechanisms to promote EGFR endocytosis as anisomycin-induced internalization does not require tyrosine kinase activity or ubiquitination of the receptor. Incubation with a specific inhibitor of p38, or depletion of endogenous p38 by small interfering RNA (siRNA), abolished anisomycin-induced internalization of EGFR while having no effect on transferrin endocytosis. Interestingly, inhibition of p38 activation also abolished endocytosis of EGFR induced by UV radiation. These results suggest that stimulation of EGFR internalization by p38 might represent a general mechanism to prevent generation of proliferative or anti-apoptotic signals under stress conditions. While further studies will be required to assess the specific mechanisms used by p38 to regulate EGFR internalization, our results strengthen the idea that there is a clear intercommunication between signaling and intracellular traffic and suggest that p38 is a key player in this process.

Selected Publications:

Puertollano R. Clathrin-mediated transport: assembly required. EMBO Reports. 2004; 5: 942-946.

Puertollano R. Interactions of TOM1L1 with the multivesicular body sorting machinery. Journal of Biological Chemistry. 2005; 280: 9258-9264.

Vergarajauregui S. and Puertollano R. Two Di-leucine Motifs Regulate Trafficking of Mucolipin-1 to Lysosomes . 2006. Traffic. 2006; In press.

Questions, comments and suggestions about this page may be addressed to Rosa Puertollano

 

jump over rollover images to navigation links

NHLBI HOME · SEARCH NHLBI · ACCESSIBILITY INFORMATION · NHLBI SITE INDEX · OTHER SITES · PRIVACY STATEMENT · FOIA · CONTACT NHLBI

Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute